TL/DR -
The cost of insulin for Medicare beneficiaries in the United States has been significantly reduced to an average of $35 per month, according to President Joe Biden. This reduction is due to recent changes by the federal government and drug manufacturers, as well as the Inflation Reduction Act that Biden signed in 2022, which capped…
TL/DR -
A recent survey by PhRMA reveals that having health insurance doesn't always guarantee optimal healthcare outcomes for Americans with concerns about out-of-pocket costs and access to necessary medications being identified as significant barriers. Forty percent of insured adults reported postponing medical treatment due to cost, and 38% of…